As March begins, the stock market promises a high playground to turn modest investments into massive wealth. Amidst this enthusiasm, three top stock picks for rally stand out as pillars of opportunity

Under the Radar: 3 Overlooked Stocks Ready to Dominate the Market

12:22pm, Monday, 26'th Feb 2024

Some stocks glitter more prominently than others in the vast investment pool. However, amidst the popularity of high-profile names, a line of overlooked stocks exists, steadily leading to a market edg

Don't Overlook These Low-Risk High-Dividend Yielding Stocks

08:01pm, Friday, 23'rd Feb 2024

Now looks like a good time to buy these highly ranked stocks with earnings estimate revisions likely to keep ticking up after their favorable Q4 results which makes their high dividend yields and low

Top 5 Low-Beta High-Yielding Stocks to Shield Your Portfolio

09:26am, Friday, 16'th Feb 2024

U.S. stock markets are facing fluctuations in early 2024 after a sharp rally in 2023. The euphoria surrounding technology stocks evaporated as the yield on the benchmark 10-Year U.S. Treasury Note ret

Organon & Co. (OGN) Q4 2023 Earnings Call Transcript

12:06pm, Thursday, 15'th Feb 2024

Organon & Co. (OGN) Q4 2023 Earnings Call Transcript

Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

12:01pm, Thursday, 15'th Feb 2024

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 15, 2024

07:30am, Thursday, 01'st Feb 2024

JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon will release fourth quarter and full year 2023 financial results on February 15, 2024, and hold a webcast and conference call at 8:30 AM EST.

Organon & Co (OGN) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

10:55pm, Tuesday, 09'th Jan 2024

Organon & Co (OGN) J.P. Morgan 42nd Annual Healthcare Conference (Transcript)

Organon: What I'm Looking For In This 8% Yield In 2024

08:10am, Wednesday, 03'rd Jan 2024

Organon, a pharmaceutical company, has a diverse portfolio of products in women's health and biosimilars. The company has faced challenges in its women's health segment but expects a turnaround in its

11 dividend stocks with high yields expected to be well supported in 2024 per strict criteria

10:18am, Wednesday, 27'th Dec 2023

Investors have different approaches to stock dividends. Some have no interest in current income and would prefer companies to focus on growing their businesses, rather than distributing cash to shareh

High Risk, High Reward: Why 8.5%-Yielding Organon Could Be Up To 90% Undervalued

10:22am, Tuesday, 19'th Dec 2023

Organon's stock has declined 32% since September, making it one of the worst performers in healthcare. The company reported mixed financial results, with 1% growth in product sales and a decline in to

Jenny Harrington's top dividend picks for 2024: OGN, NYCB, WHR, CWEN, OKE, CCI and STX

04:46pm, Tuesday, 12'th Dec 2023

Jenny Harrington, Gilman Hill Asset Management CEO, discusses her top dividend picks for 2024.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by